Maternal immunisation against Group B Streptococcus: a global analysis of health impact and cost-effectiveness

BackgroundGroup B Streptococcus (GBS) can cause invasive disease (iGBS) in young infants, typically presenting as sepsis or meningitis, and is also associated with stillbirth and preterm birth. GBS vaccines are under development, but their potential health impact and cost-effectiveness have not been assessed globally. MethodsWe assessed the health impact and value... Show more